Drug Approval Package

 Ery-Ped (Erythromycin Ethylsuccinate) Oral Suspention & E.E.S. Granules Oral Suspension
Company:  Abbott Laboratories
Application No.:  050207S054 & 050207S055
Approval Date: 2/04/2000

• Approval Letter(s) (PDF)

• Microbiology Review(s) (PDF)  

• Administrative Document(s) & Correspondence (PDF)  

Date created: October 212004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.